Apollomics, Inc.
APLMNASDAQHealthcare● Active
$14.00
+$0.00(+0.00%)
Market Cap$15446872
P/E Ratio—
52W High$42.12
52W Low$3.659
Apollomics, Inc. (APLM) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · APLM · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($10.94M) | ($53.86M) | ($172.60M) | ($240.81M) | ($94.80M) |
| Depreciation & Amort. | $0.26M | $0.36M | $0.67M | $0.78M | $0.68M |
| Stock-Based Comp. | ($0.98M) | $10.93M | $12.69M | $3.58M | $8.12M |
| Change in Working Capital | ($0.38M) | $1.61M | ($0.93M) | $3.65M | ($0.45M) |
| Net Cash from Operations | ($10.37M) | ($28.74M) | ($43.21M) | ($42.82M) | ($43.31M) |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | ($0.02M) | ($0.01M) | ($0.37M) | ($0.05M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | $0.22M | $5.98M | $21.36M | $29.05M | ($38.95M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $3.73M | ($0.17M) | ($0.44M) | ($0.59M) | ($0.53M) |
| Net Cash from Financing | $3.68M | $0.47M | $21.23M | ($0.29M) | ($1.64M) |
| Free Cash Flow | |||||
| Free Cash Flow | ($10.37M) | ($28.77M) | ($43.22M) | ($43.19M) | ($43.36M) |
| FCF Margin %(computed) | -121.99% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Apollomics, Inc. data
About Apollomics, Inc. (APLM) Cash Flow Statement
Apollomics, Inc. generated operating cash flow of ($0.01B) and free cash flow of ($0.01B) for 2025 — a FCF margin of -121.99%. Capital expenditure was $0.00B.
Frequently asked questions
APLM · 4 questionsApollomics, Inc. generated free cash flow of ($0.01B) for 2025, up 64.0% year-over-year.
APLM free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10